ABOUT ELS

The European Leptospirosis Society (ELS) was formed in 2012 in order to promote knowledge on leptospirosis and related haemorrhagic fevers through the organisation of regional meetings, networking between European institutions and to facilitate fund raising for research on the subject.

Officers & Board Members

Marga Goris (The Netherlands)       President

Mathieu Picardeau (France)             Vice-President

Jarlath Nally (Ireland)                      Secretary

Josipa Habus (Croatia)                     Treasurer

Marcella Mori (Belgium)

Nicoletta Ponti (Italy)

Eric Klaasen (The Netherlands)
Eric van Gorp (The Netherlands)

Sreekumari Rajeev (U.S.A)

Lionel Cupillard (France)

Marco Goeijenbier (The Netherlands)
Zbigniew Arent (Poland)

Jiri Wagenaar (The Netherlands)

Simone Schuller (Switzerland)
Emanuella Gutu (Romania)

Barry Rockx (The Netherlands)

Anou Dreyfus (Switzerland)

Alexander Panin (Russia)

Nenad Turk (Croatia)

Objectives of the Society:

  • To create awareness about leptospirosis and rodent borne diseases among medical and veterinary professionals, scientists, health planners, policy makers and the general public in different parts of the world.

  • To organise a European scientific meeting of the Society, triennially or as appropriate.

  • To facilitate communication and  distribute scientifically relevant publications, among those with an interest in leptospirosis, with a focus on, but not exclusively limited to, Europe (including the EU and The Russian Federation), the Middle East and Africa (ERMA).

  • To provide up-to-date epidemiological information on leptospirosis to international and national health authorities as requested.

  • To provide or support internationally available services including training and education as appropriate that will assist with the diagnosis of leptospirosis, research into leptospirosis and the control or treatment of leptospirosis and related haemorrhagic fevers.

  • To promote harmonisation in the diagnosis of leptospirosis among European laboratories and build databases of comparable epidemiological data.

  • To present a consortium that acts as a partner in fund raising for research on leptospirosis and related haemorrhagic fevers.